| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,123 | 86,799 | 98,489 | 93,578 | | Cost of Revenue | 44,454 | 55,762 | 39,529 | 56,142 | | | Gross Profit | 53,669 | 31,037 | 58,960 | 37,436 | | | Operating Expenses | | Research Development | 10,385 | 10,584 | 9,306 | 11,610 | | Selling General and Administrative | 16,908 | 19,351 | 18,424 | 26,728 | | Non Recurring | 1,718 | 185 | 8,171 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,658 | 917 | 23,059 | (902) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 14 | 19 | 41 | | Earnings Before Interest And Taxes | 22,721 | 6,512 | 20,078 | 6,789 | | Interest Expense | 365 | 365 | 333 | 692 | | Income Before Tax | 22,356 | 6,147 | 19,745 | 6,097 | | Income Tax Expense | 8,637 | 2,651 | 7,404 | 2,715 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,719 | 3,496 | 12,341 | 3,382 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (24) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,719 | 3,496 | 12,341 | 3,358 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,719 | $3,496 | $12,341 | $3,358 |
|
0.31% Nasdaq 0.00%
Income Statement
